Rigel reports Q4 revenue of $69.8 million, projects 2026 growth
Go back to Rigel reports Q4 revenue of $69.8 million, projects 2026 growth| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 46.86 +0.38 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.48 | 52 Week High | $4.38 | |||
| Open | $46.29 | 52 Week Low | $1.88 | |||
| Day High | $47.00 | P/E | N/A | |||
| Day Low | $45.61 | EPS | $-1.12 | |||
| Volume | 188,623 | |||||
